| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 08/13/2013 | US8507684 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts |
| 08/13/2013 | US8507682 Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (S1P2) receptors |
| 08/13/2013 | US8507509 Saturated and insaturated bi- or tricyclic aryloxyacetamine derivatives and their use as fungicides |
| 08/08/2013 | WO2013115793A1 Iron chelators and uses thereof |
| 08/08/2013 | WO2013032273A3 Quinolinium single crystals for use in nonlinear optics |
| 08/08/2013 | US20130204000 Crystal form of quinoline compound and process for its production |
| 08/08/2013 | US20130203733 Compositions and methods for modulating interaction between polypeptides |
| 08/08/2013 | US20130203727 Napht-2-ylacetic acid derivatives to treat aids |
| 08/08/2013 | US20130203703 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators |
| 08/08/2013 | US20130203689 Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof |
| 08/08/2013 | US20130202536 Fluorophore chelated lanthanide luminescent probes with improved quantum efficiency |
| 08/07/2013 | EP2621904A2 Compounds as c-met kinase inhibitors |
| 08/07/2013 | EP2621903A1 N-heteroaryl compounds |
| 08/07/2013 | CN103232444A Naphthoquine derivatives, and preparation and application thereof |
| 08/07/2013 | CN102036962B Combined use of angiogenesis inhibitor and taxane |
| 08/06/2013 | US8501937 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 08/06/2013 | US8501732 Aminomethyl quinolone compounds |
| 08/06/2013 | CA2752421C Amino ester derivatives, salts thereof and methods of use |
| 08/06/2013 | CA2679852C Method for producing quinolone carboxylic acid derivative |
| 08/01/2013 | US20130197231 Inhibitors of human immunodeficiency virus replication |
| 08/01/2013 | US20130197230 Methods of preparing quinoline derivatives |
| 08/01/2013 | US20130197022 3-cyano-quinoline derivatives with antiproliferative activity |
| 07/31/2013 | CN103228631A Kat II inhibitors |
| 07/31/2013 | CN103224466A Compound with beta-secretase inhibition function, its preparation method and application |
| 07/31/2013 | CN102212032B 5-hyroxyquinolone derivatives, and preparation method and application thereof |
| 07/31/2013 | CN101885653B Synthesis method of N-heteroaryl amino acid |
| 07/31/2013 | CN101818056B Dansyl molecular probe and synthetic method and application thereof |
| 07/30/2013 | US8497378 Process for making quinolone compounds |
| 07/30/2013 | US8497284 C-met modulators and method of use |
| 07/25/2013 | WO2013108921A1 Industrial process for preparation of 1,2-dihydroquinoline derivative or a salt thereof, and intermediate for preparation thereof |
| 07/25/2013 | WO2013108644A1 Rebamipide therapeutic agent for allergic conjunctivitis |
| 07/25/2013 | WO2012111021A8 Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of alzheimer's disease |
| 07/25/2013 | US20130190500 Process to prepare 6-chloro-3-amino-2-(2-hydroxypropyl)-1-azanaphthalene |
| 07/25/2013 | US20130190491 Inhibitors of human immunodeficiency virus replication |
| 07/25/2013 | US20130190315 Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation |
| 07/25/2013 | US20130190296 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 07/24/2013 | EP2617714A1 Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof |
| 07/24/2013 | EP2616442A1 Inhibitors of pi3k-delta and methods of their use and manufacture |
| 07/24/2013 | CN103221393A Production method for 4-carbonyl oxyquinoline derivative |
| 07/24/2013 | CN103214416A Method for synthesizing multi-substituted quinoline compound |
| 07/24/2013 | CN103214415A Preparation method of aripiprazole and key intermediate of aripiprazole |
| 07/24/2013 | CN103214337A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/24/2013 | CN102140078B Improved scraup method for preparing quinoline or quinoline derivatives |
| 07/24/2013 | CN101815703B Novel fungicides |
| 07/24/2013 | CN101792422B Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/24/2013 | CN101730684B Sulfonyl-quinoline derivatives |
| 07/24/2013 | CN101531599B Green electroluminescent compounds and organic electroluminescent device using the same |
| 07/23/2013 | US8492568 Chromane derivatives as TRPV3 modulators |
| 07/23/2013 | US8492404 Bis-aryl amide compounds and methods of use |
| 07/23/2013 | CA2607106C 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
| 07/18/2013 | WO2013106847A1 Compounds, compositions and associated methods comprising 3-aryl quinolines |
| 07/18/2013 | WO2013106819A2 Zinc-responsive peptides, and methods of use thereof |
| 07/18/2013 | WO2013055944A3 Labile esters of agrochemicals for controlled release and reduction of off-site movement |
| 07/18/2013 | US20130184464 Novel montelukast 4-halobenzylamine salt and method for preparing montelukast sodium salt by using the same |
| 07/17/2013 | EP2614069A1 Biaryl diphosphine ligands, intermediates of the same and their use in asymmetric catalysis |
| 07/17/2013 | EP2613775A1 Novel n-hydroxy-benzamides for the treatment of cancer |
| 07/17/2013 | CN103209963A 2-quinolinyl-acetic acid derivatives as HIV antiviral compounds |
| 07/17/2013 | CN103204903A Hepatitis c inhibitor compounds |
| 07/17/2013 | CN103204808A Biquinoline derivative, preparation method thereof and application thereof in preparing anticancer medicament |
| 07/17/2013 | CN103204807A Synthetic method of 2-cyclopropyl-4-(4-fluoro-phenyl)-3-quinolinecarboxaldehyde |
| 07/17/2013 | CN101998951B Acylthiourea compound or salt thereof, and use thereof |
| 07/17/2013 | CN101541752B 抗菌的喹啉衍生物 Antibacterial quinoline derivatives |
| 07/16/2013 | US8487105 Process for preparing pitavastatin, intermediates and pharmaceuctically acceptable salts thereof |
| 07/16/2013 | US8487104 KAT II inhibitors |
| 07/16/2013 | US8487103 Quinoline inhibitors of hepatitis C virus polymerase |
| 07/16/2013 | US8486969 Therapeutic compounds |
| 07/11/2013 | WO2013103724A1 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids |
| 07/11/2013 | WO2013103148A1 Collateral blood circulation development promoter |
| 07/11/2013 | WO2013102936A1 N-(3-((diethylamino) methyl)-4-hydroxyphenyl)-n-(quinolin-4-yl) sulfonamides for the treatment of tuberculosis and process of preparation thereof |
| 07/11/2013 | WO2012174121A3 Decoquinate prodrugs |
| 07/11/2013 | US20130178631 Novel alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 07/11/2013 | US20130178499 Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors |
| 07/11/2013 | US20130178494 Phenyl n-mustard linked to dna-affinic molecules or water-soluble aryl rings, method and their use as cancer therapeutic agents |
| 07/10/2013 | EP2612853A1 c-Met modulators and methods of use |
| 07/10/2013 | EP2612852A1 Theramutein modulators |
| 07/10/2013 | CN103201261A Lactam derivatives useful as orexin receptor antagonists |
| 07/10/2013 | CN103200936A Novel n-hydroxy-benzamides for the treatment of cancer |
| 07/10/2013 | CN103193706A Method for producing cloquintocet-mexyl |
| 07/10/2013 | CN103193702A Functionalization method for nitrogenous heterocyclic compound |
| 07/10/2013 | CN103193568A Selective hydrogenation reduction method of fluorine-containing aromatic hydrocarbon derivative |
| 07/10/2013 | CN103193567A Method for controllable reduction of unsaturated organic compound from catalysis of formic acid by nanogold |
| 07/10/2013 | CN102070523B Novel method for preparing 3-hydroxylquinaldine-4-carboxylic acid |
| 07/10/2013 | CN101638383B Quinoline as well as pharmaceutical composition and use thereof |
| 07/09/2013 | US8481742 Fused aromatic PTP-1B inhibitors |
| 07/09/2013 | US8481741 Preparation methods of 6 substituted amino-3 cyanoquinoline compounds and the intermediates thereof |
| 07/09/2013 | US8481659 Cure accelerators for anaerobic curable compositions |
| 07/09/2013 | US8481543 Compounds for treating parasitic disease |
| 07/09/2013 | US8481534 5- and 6-membered heterocyclic compounds |
| 07/09/2013 | US8481525 Kinase inhibitors and method of treating cancer with same |
| 07/09/2013 | CA2520323C Tie-2 modulators and methods of use |
| 07/04/2013 | WO2013098773A1 Crystalline forms of pitavastatin calcium |
| 07/04/2013 | WO2013051901A3 Novel adamantane derivative compound 신규 아다만탄 유도체 화합물 |
| 07/04/2013 | WO2013051024A3 Quinoline-, quinoxaline or benzothiazole based cysteinyl leukotriene antagonists (ltc4) |
| 07/04/2013 | US20130172363 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 07/04/2013 | US20130172346 Use of kynurenic acid amide derivatives for the treatment of huntington's disease |
| 07/04/2013 | US20130172345 1-acyl-4-(phenoxy, benzyloxy, or phenylamino)-1,2,3,4-tetrahydroquinoline derivatives |
| 07/04/2013 | US20130172344 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 07/04/2013 | US20130172337 Imidazo[4,5-c]quinolines as DNA-PK inhibitors |
| 07/04/2013 | US20130172334 Trpv1 antagonists |
| 07/04/2013 | DE102007061630B4 Neue Verbindungen und Herstellung von Montelukast-Natrium New connections and preparation of montelukast sodium |